A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial.
暂无分享,去创建一个
L. Mackillop | K. Tucker | R. McManus | A. Nickless | L. Chappell | L. Pealing | C. Crawford | H. Wilson | E. Temple | Eleanor Temple
[1] Amy E. Judy,et al. Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California. , 2019, Obstetrics and gynecology.
[2] Karim Ladha,et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial , 2018, The Lancet.
[3] L. Hinton,et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study , 2017, BMC Pregnancy and Childbirth.
[4] L. Hinton,et al. Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women’s experiences of self-monitoring , 2017, BMC Pregnancy and Childbirth.
[5] Bonnie J Wakefield,et al. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis , 2017, PLoS medicine.
[6] P. Seed,et al. Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta‐Analysis , 2017, Journal of the American Heart Association.
[7] Daniel Hind,et al. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme , 2017, BMJ Open.
[8] G. Molenberghs,et al. Remote Monitoring of Hypertension Diseases in Pregnancy: A Pilot Study , 2017, JMIR mHealth and uHealth.
[9] J. Singer,et al. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study) , 2016, Hypertension.
[10] A. Khalil,et al. Evaluation of home monitoring of hypertension in pregnancy , 2016 .
[11] J. Singer,et al. Less-tight versus tight control of hypertension in pregnancy. , 2015, The New England journal of medicine.
[12] J. Singer,et al. Less-tight versus tight control of hypertension in pregnancy. , 2015, The New England journal of medicine.
[13] S. Kenyon,et al. Saving Lives, Improving Mothers' Care: Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-2012 , 2014 .
[14] Emma P Bray,et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. , 2014, JAMA.
[15] M. Teare,et al. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study , 2014, Trials.
[16] L. Magee,et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. , 2014, Pregnancy hypertension.
[17] D. Henderson-smart,et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.
[18] Emma P Bray,et al. Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.
[19] A. Shennan,et al. Validation and Compliance of a Home Monitoring Device in Pregnancy: Microlife WatchBP Home , 2009, Hypertension in pregnancy.
[20] Pierre Corvol,et al. Self-measurement and self-titration in hypertension: a pilot telemedicine study. , 2007, American journal of hypertension.
[21] J. Singer,et al. Women's Views of Their Experiences in the CHIPS (Control of Hypertension in Pregnancy Study) Pilot Trial , 2007, Hypertension in pregnancy.
[22] A Metin Gülmezoglu,et al. WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.
[23] John E. Brazier,et al. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.
[24] P. Roderick,et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring , 2004, Transplantation.
[25] D. Mant,et al. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care , 2002, BMJ : British Medical Journal.
[26] J. Hewison,et al. Antenatal home blood pressure monitoring: a pilot randomised controlled trial , 2000, BJOG : an international journal of obstetrics and gynaecology.
[27] J. Weinman,et al. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.
[28] S. Office. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-1993 , 1996 .
[29] C. Redman,et al. Eclampsia in the United Kingdom , 1994, BMJ.
[30] T. Marteau,et al. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). , 1992, The British journal of clinical psychology.
[31] Carmelo Velardo,et al. Self-Management of Postnatal Hypertension: The SNAP-HT Trial , 2018, Hypertension.
[32] M. S. Gupta,et al. Systolic hypertension. , 1984, Journal of the Indian Medical Association.